FineImmu vs ImCheck Therapeutics
FineImmu
Creating future health with advanced cell therapy drugs and precision immunodiagnostic products
est. 2018
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
57 employees · est. 2015 · Marseille, France
ImCheck Therapeutics is the older company (2018 vs 2015).
Side-by-Side Comparison
| Metric | FineImmu | ImCheck Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2015 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Marseille, France |
| Employees | ||
| Employees | Not tracked yet | 57 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Grant |
| Total Funding | ||
| Total Funding | $90.00M | $193.11M |
| Funding Rounds | ||
| Funding Rounds | 1 | 7 |
| Services | ||
| Services | Not tracked yet | development of immunotherapeutic antibodies, immune system modulation research, clinical research in AML patients |
| Target Customers | ||
| Target Customers | Not tracked yet | patients with cancer, patients with infectious diseases, patients with autoimmune diseases |
| Taxonomy | ||
| Taxonomy | Cell TherapyImmunotherapyPrecision MedicineImmunodiagnosticPD-1PD-L1 +4 | ImmunotherapyOncologyAntibody TherapeuticsCancer TreatmentImmune Checkpoint InhibitorsAutoimmune Diseases +4 |
| Website | ||
| Website | fineimmu.com | imchecktherapeutics.com |
About FineImmu
FineImmu, established in 2018, is a biopharmaceutical and biotechnology startup dedicated to revolutionizing healthcare with advanced cell therapy drugs and precision immunodiagnostic products. The company's slogan "Creating future health with advanced cell therapy drugs and precision immunodiagnost...
About ImCheck Therapeutics
ImCheck Therapeutics, with the slogan "Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic," is focused on designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. Their lead clinica...
Also comparing in this category
Comparing more than these two?
Get FineImmu, ImCheck Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does FineImmu compare?
A PDF of FineImmu and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare FineImmu with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at FineImmu on 12 Sep 2024, and ImCheck Therapeutics on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
